ATS 2021 will feature presentations of original research from accepted abstracts. Mini Symposia and Thematic Poster Sessions are abstract based sessions.
Please use the form below to browse scientific abstracts and case reports accepted for ATS 2021. Abstracts presented at the ATS 2021 will be published in the Online Abstract Issue of the American Journal of Respiratory and Critical Care Medicine, Volume 203, May 3, 2021.
Search Tips:
- Use the keyword search to search by keyword or author's name.
- Filter your search results by selecting the checkboxes that apply.
- Click on "Clear" to clear the form and start a new search. .
Search results will display below the form.
Factors Associated with Hospitalization Length of Stay in Patients with COVID-19, a Multivariable Analysis
Session Title
TP51 - TP051 COVID: LUNG INFECTION, MULTIORGAN FAILURE, AND CARDIOVASCULAR
Abstract
A2639 - Factors Associated with Hospitalization Length of Stay in Patients with COVID-19, a Multivariable Analysis
Author Block: C. N. Myers1, J. Kim2, P. Stanley1, N. Guo1, A. George3, E. Narewski1, G. J. Criner1; 1Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, PA, United States, 2Department of Internal Medicine, Temple University Hospital, Philadelphia, PA, United States, 3Department of Respiratory Therapy, Temple University Hospital, Philadelphia, PA, United States.
Background: Coronavirus disease 2019 (COVID-19) is the cause of a global pandemic which has strained the resources of health systems around the world. Health systems, patients, and healthcare providers may benefit from knowledge regarding which factors predict length of stay (LOS), and therefore healthcare resource allocation, in patients presenting with COVID-19.
Methods: 559 patients were retrospectively identified who were admitted to Temple University Hospital in Philadelphia, PA between February and May of 2020. All patients tested positive for COVID-19 by nasopharyngeal swab and received computed tomography screening for viral pneumonia. We collected data present at time of hospital admission and performed a retrospective analysis to determine factors associated with hospital LOS.
Results: Mean hospital LOS for our cohort was 9.0 days. In this cohort, most patients received antibiotics. 100% of patients received glucocorticoids and 8.1% received remdesivir. 31.2% participated in clinical trials of monoclonal antibodies. 26.8% of patients required intensive care during their hospitalization, 17.4% required invasive or noninvasive mechanical ventilation, and 11.1% died. On multivariable linear regression analysis, increasing leukocyte count and a diagnosis of diabetes mellitus predicted decreased LOS. Increased respiratory support within the first 24 hours, patient age, creatinine, and total bilirubin were associated with increased LOS.
Conclusion: Patient past medical history, admission laboratory values, and severity of hypoxemia at hospital admission may predict LOS in patients hospitalized for COVID-19.
Author Block: C. N. Myers1, J. Kim2, P. Stanley1, N. Guo1, A. George3, E. Narewski1, G. J. Criner1; 1Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, PA, United States, 2Department of Internal Medicine, Temple University Hospital, Philadelphia, PA, United States, 3Department of Respiratory Therapy, Temple University Hospital, Philadelphia, PA, United States.
Background: Coronavirus disease 2019 (COVID-19) is the cause of a global pandemic which has strained the resources of health systems around the world. Health systems, patients, and healthcare providers may benefit from knowledge regarding which factors predict length of stay (LOS), and therefore healthcare resource allocation, in patients presenting with COVID-19.
Methods: 559 patients were retrospectively identified who were admitted to Temple University Hospital in Philadelphia, PA between February and May of 2020. All patients tested positive for COVID-19 by nasopharyngeal swab and received computed tomography screening for viral pneumonia. We collected data present at time of hospital admission and performed a retrospective analysis to determine factors associated with hospital LOS.
Results: Mean hospital LOS for our cohort was 9.0 days. In this cohort, most patients received antibiotics. 100% of patients received glucocorticoids and 8.1% received remdesivir. 31.2% participated in clinical trials of monoclonal antibodies. 26.8% of patients required intensive care during their hospitalization, 17.4% required invasive or noninvasive mechanical ventilation, and 11.1% died. On multivariable linear regression analysis, increasing leukocyte count and a diagnosis of diabetes mellitus predicted decreased LOS. Increased respiratory support within the first 24 hours, patient age, creatinine, and total bilirubin were associated with increased LOS.
Conclusion: Patient past medical history, admission laboratory values, and severity of hypoxemia at hospital admission may predict LOS in patients hospitalized for COVID-19.
